A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita

Molecular Endocrinology

Volumn 11, Issue 13, 1997, Pages 1950-1960

  Lalli, Enzo ^a   Bardoni, Barbara ^a,b   Zazopoulos, Emmanuel ^a   Wurtz, Jean Marie ^a   Strom, Tim M ^c   Moras, Dino ^a   Sassone Corsi, Paolo ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL DISEASE; ANIMAL CELL; ARTICLE; GENE MUTATION; GENE REPRESSION; HUMAN; HYPOPLASIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION; X CHROMOSOME LINKED DISORDER;

ANIMALIA;

EID: 0030780854     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.13.0038     Document Type: Article

References (36)

1. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley KC, Tonini G, Ferrante E, Chiumello G, McCabe ERB, Fraccaro M, Zuffardi O, Camerino GA 1994 Dosage-sensitive locus at chromosome Xp 21 is involved in male to female sex reversal. Nat Genet 7:497-501
2. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ERB, Meitinger T, Monaco AP, Sassone-Corsi P, Camerino G 1994 An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635-641
3. Muscatelli F, Strom TM, Walker AP, Zanaria E, Récan D, Meindl A, Bardoni B, Guioli S, Zehetner G, Rabl W, Schwarz HP, Kaplan JC, Camerino G, Meitinger, T, Monaco AP 1994 Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita, hypogonadotropic hypogonadism. Nature 372:672-676
4. Guo W, Mason JS, Stone CG, Morgan SA, Madu SI, Baldini A, Lindsay EA, Biesecker LG, Copeland KC, Horlick MNB, Pettigrew AL, Zanaria E, McCabe ERB 1995 Diagnosis of X-linked adrenal hypoplasia congenita by mutation analysis of the DAX 1 gene. JAMA 274:324-330
5. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF, Jameson JL 1996 Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX- 1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 98:1055-1062
6. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P, DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature, in press
7. Baniahmad A, Köhne AC, Renkawitz RA 1992 Transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J 11:1015-1023
8. Cooney AJ, Leng X, Tsai SY, O'Malley BW, Tsai M-J 1993 Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors. J Biol Chem 268:4152-4160
9. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
10. Chen JD, Evans RMA 1995 Transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
11. Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK 1995 Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454
12. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR α. Nature 375:377-382
13. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
14. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
15. Wurtz J-M, Bourguet W, Renaud J-P, Vivat V, Chambon P, Moras D, Gronemeyer HA 1996 Canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3:87-94
16. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G 1996 Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal, hypothalamus function. Nat Genet 12:404-409
17. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033
18. Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P 1994 Activation function 2 (AF-2) of retinoic acid receptor, 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain, influence of the nature of the response element on AF-2 activity. EMBO J 13:5370-5382
19. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai M-J, O'Malley BW 1995 The τ 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15:76-86
20. Baniahmad A, Tsai SY, O'Malley BW, Tsai M-J 1992 Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses. Proc Natl Acad Sci USA 89:10633-10637
21. Zenke M, Munoz A, Sap J, Vennström B, Beug H 1990 v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erb A. Cell 61:1035-1049
22. Carroll SB, Scott MP 1986 Zygotically active genes that affect the spatial expression of the fushi tarazu segmentation gene during early Drosophila embryogenesis. Cell 45:113-126
23. White KP, Hurban P, Watanabe T, Hogness DS 1997 Coordination of Drosophila metamorphosis by two ecdysone-induced nuclear receptors. Science 276:114-117
24. Park S, Tomlinson G, Nisen P, Haber DA 1993 Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor. Cancer Res 53:4757-4760
25. Zamir, I, Harding HP, Atkins GB, Hörlein A, Glass CK, Rosenfeld MG, Lazar MA 1996 A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16:5458-5465
26. Ito M, Yu R, Jameson JL 1997 DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 17:1476-1483
27. Thompson JD, Higgins DG, Gibson TJ 1994 ClustalW: improving the sensitivity of multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680
28. Sali A, Blundell TL 1993 Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815
29. Laskowski RA, MacArthur MW, Moss DS, Thornton JM 1993 PROCHECK: a program to check the stereochemical quality of proteins structures. J Appl Cryst 26:283-291
30. Sippl MJ 1993 Recognition of errors in three-dimensional structures of proteins. Proteins 17:355-362
31. Laoide BM, Foulkes NS, Schlotter F, Sassone-Corsi P 1993 The functional versatility of CREM is determined by its modular structure. EMBO J 12:1179-1191
32. Sugawara T, Lin D, Holt JA, Martin KO, Javitt NB, Miller WL, Strauss III JF 1995 Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry 34:12506-12512
33. G is a transcriptional enhancer in human HeLa cells in the presence of the GAL 4 trans-activator. Cell 521:69-178
34. Cullen BR 1987 Use of eucaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704
35. Barton GJ 1993 ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng 6:37-40
36. Evans SV (1993) SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J Mol Graphics 11:134-138